Triage for selection to colonoscopy?

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Triage for selection to colonoscopy? / For the Danish Collaborative Group on Early Detection of Colorectal Neoplasia.

In: European Journal of Surgical Oncology, Vol. 44, No. 10, 2018, p. 1539-1541.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

For the Danish Collaborative Group on Early Detection of Colorectal Neoplasia 2018, 'Triage for selection to colonoscopy?', European Journal of Surgical Oncology, vol. 44, no. 10, pp. 1539-1541. https://doi.org/10.1016/j.ejso.2018.06.013

APA

For the Danish Collaborative Group on Early Detection of Colorectal Neoplasia (2018). Triage for selection to colonoscopy? European Journal of Surgical Oncology, 44(10), 1539-1541. https://doi.org/10.1016/j.ejso.2018.06.013

Vancouver

For the Danish Collaborative Group on Early Detection of Colorectal Neoplasia. Triage for selection to colonoscopy? European Journal of Surgical Oncology. 2018;44(10):1539-1541. https://doi.org/10.1016/j.ejso.2018.06.013

Author

For the Danish Collaborative Group on Early Detection of Colorectal Neoplasia. / Triage for selection to colonoscopy?. In: European Journal of Surgical Oncology. 2018 ; Vol. 44, No. 10. pp. 1539-1541.

Bibtex

@article{bf0fc6f9ad454e60aeef6d786e836384,
title = "Triage for selection to colonoscopy?",
abstract = "Implementation of population screening for colorectal cancer by direct colonoscopy or follow-up colonoscopy after a positive fecal blood test has challenged the overall capacity of bowel examinations. Certain countries are facing serious colonoscopy capacity constraints, which have led to waiting lists and long-time latency of follow-up examinations. Various options for improvement are considered, including increased cut-off values of the fecal blood tests. Results from major clinical studies of blood-based, cancer-associated biomarkers have led to focus, however, on a triage concept for improved selection to colonoscopy. The triage test may include subject age, concentration of hemoglobin in a feces test and a combination of certain blood-based cancer associated biomarkers. Recent results have indicated that triage may reduce the requirements for colonoscopy by around 30%. Such results may be advantageous for the capacity, the heath budgets and in particular, the subjects, who do not need an unnecessary, unpleasant and risk-associated bowel examination.",
keywords = "Biomarkers, Blood test, Colonoscopy, Colorectal cancer, Screening, Triage",
author = "Mathias Mertz-Petersen and Piper, {Thomas B.} and Jakob Kleif and Linnea Ferm and Christensen, {Ib Jarle} and Nielsen, {Hans J.} and J{\o}rgensen, {Lars Nannestad} and Morten Rasmussen and Jakob Hendel and Madsen, {Mogens R.} and Madsen, {Anders Husted} and Jesper Vilandt and Thore Hillig and Karina Willemoes and S{\o}ren Brandsborg and Michael Kl{\ae}rke and Andersen, {Berit S.} and Nete Hornung and K{\aa}re Sunesen and Andersen, {Claus L.} and Erland Erlandsen and Ali Kahlid and {For the Danish Collaborative Group on Early Detection of Colorectal Neoplasia}",
year = "2018",
doi = "10.1016/j.ejso.2018.06.013",
language = "English",
volume = "44",
pages = "1539--1541",
journal = "European Journal of Surgical Oncology",
issn = "0748-7983",
publisher = "Elsevier",
number = "10",

}

RIS

TY - JOUR

T1 - Triage for selection to colonoscopy?

AU - Mertz-Petersen, Mathias

AU - Piper, Thomas B.

AU - Kleif, Jakob

AU - Ferm, Linnea

AU - Christensen, Ib Jarle

AU - Nielsen, Hans J.

AU - Jørgensen, Lars Nannestad

AU - Rasmussen, Morten

AU - Hendel, Jakob

AU - Madsen, Mogens R.

AU - Madsen, Anders Husted

AU - Vilandt, Jesper

AU - Hillig, Thore

AU - Willemoes, Karina

AU - Brandsborg, Søren

AU - Klærke, Michael

AU - Andersen, Berit S.

AU - Hornung, Nete

AU - Sunesen, Kåre

AU - Andersen, Claus L.

AU - Erlandsen, Erland

AU - Kahlid, Ali

AU - For the Danish Collaborative Group on Early Detection of Colorectal Neoplasia

PY - 2018

Y1 - 2018

N2 - Implementation of population screening for colorectal cancer by direct colonoscopy or follow-up colonoscopy after a positive fecal blood test has challenged the overall capacity of bowel examinations. Certain countries are facing serious colonoscopy capacity constraints, which have led to waiting lists and long-time latency of follow-up examinations. Various options for improvement are considered, including increased cut-off values of the fecal blood tests. Results from major clinical studies of blood-based, cancer-associated biomarkers have led to focus, however, on a triage concept for improved selection to colonoscopy. The triage test may include subject age, concentration of hemoglobin in a feces test and a combination of certain blood-based cancer associated biomarkers. Recent results have indicated that triage may reduce the requirements for colonoscopy by around 30%. Such results may be advantageous for the capacity, the heath budgets and in particular, the subjects, who do not need an unnecessary, unpleasant and risk-associated bowel examination.

AB - Implementation of population screening for colorectal cancer by direct colonoscopy or follow-up colonoscopy after a positive fecal blood test has challenged the overall capacity of bowel examinations. Certain countries are facing serious colonoscopy capacity constraints, which have led to waiting lists and long-time latency of follow-up examinations. Various options for improvement are considered, including increased cut-off values of the fecal blood tests. Results from major clinical studies of blood-based, cancer-associated biomarkers have led to focus, however, on a triage concept for improved selection to colonoscopy. The triage test may include subject age, concentration of hemoglobin in a feces test and a combination of certain blood-based cancer associated biomarkers. Recent results have indicated that triage may reduce the requirements for colonoscopy by around 30%. Such results may be advantageous for the capacity, the heath budgets and in particular, the subjects, who do not need an unnecessary, unpleasant and risk-associated bowel examination.

KW - Biomarkers

KW - Blood test

KW - Colonoscopy

KW - Colorectal cancer

KW - Screening

KW - Triage

U2 - 10.1016/j.ejso.2018.06.013

DO - 10.1016/j.ejso.2018.06.013

M3 - Journal article

C2 - 30251643

AN - SCOPUS:85049313501

VL - 44

SP - 1539

EP - 1541

JO - European Journal of Surgical Oncology

JF - European Journal of Surgical Oncology

SN - 0748-7983

IS - 10

ER -

ID: 212169355